<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>MACC1 Expression Correlates with PFKFB2 and Survival in Hepatocellular Carcinoma</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>999</FirstPage>
			<LastPage>1003</LastPage>
			<ELocationID EIdType="pii">28698</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: To validate the relationship between MACC1 and 6-phosphofructo-2-kinase/fructose 2, 6bisphosphatase (PFKFB2) expression as well as its clinicopathological features and prognostic significancein hepatocellular carcinoma. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: By using immunohistochemistry, we investigated the MACC1 andPFKFB2 protein expression in 60 pairs of hepatocellular carcinoma and corresponding non-tumor tissues.Using the Mann-Whitney U test, the Chi-square test, Kaplan-Meier survival analysis, Cox proportional hazardregression analysis and Spearman analysis, we studied the relationship between MACC1 and PFKFB2 proteinexpression and postoperative overall survival (OS) of the HCC patients. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: MACC1 and PFKFB2 positivestaining rates were significantly higher in hepatocellular carcinoma than in the corresponding nontumor tissues(P=0.012 and 0.04, respectively). The clinicopathological features evaluation revealed that positive expressionof MACC1 was associated with a high Edmondson classification (P=0.007) and advanced TNM stage (P=0.027).Similar findings were evident for PFKFB2 expression (P=0.002 and P=0.027). MACC1 and PFKFB2 positiveexpression was associated with a lower OS rate (P=0.004 and 0.03, respectively). Kaplan-Meier survival andCox proportional hazard regression analyses revealed MACC1 positive expression to be a prognostic factorfor postoperative OS, but PFKFB was not. &lt;br/&gt;&lt;b&gt;Conclusion&lt;/b&gt;: Highly expressed MACC1 and PFKFB2 protein wereassociated with TNM stage, Edmondson –Steier classification and overall survival. MACC1 may affect tumormetabolism partly through expression and phophorylation of PFKFB2.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">MACC1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PFKFB2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Glycolysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hepatocellular carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">immunohistochemistry</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28698_c9dd50e2d7d1b40b2efb406f68c2bf5a.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
